ERRT for Bipolar Disorder
(BERRT Trial)
Trial Summary
The trial requires that you have been stable on your bipolar medication for at least 2 months, so you will need to continue taking your current medications.
Research suggests that people with bipolar disorder often experience intrusive mental images that can worsen anxiety and mood instability. Treatments targeting these images, like Imagery Based Emotion Regulation, have shown potential to reduce anxiety and improve mood stability, indicating that similar approaches like ERRT-Bipolar Disorder might also be effective.
12345The available research suggests that similar therapies, like Eye Movement Desensitization and Reprocessing and Behavioral Activation, have been found to be safe for people with bipolar disorder, with no serious adverse events reported.
12678ERRT-Bipolar Disorder is unique because it focuses on using imagery techniques to help patients manage intrusive and distressing mental images, which are common in bipolar disorder and can worsen anxiety and mood instability. This approach is different from traditional therapies like cognitive behavioral therapy (CBT) by specifically targeting emotional mental imagery to improve emotional regulation.
12569Eligibility Criteria
This trial is for adults with Bipolar Disorder (I or II) who have experienced a traumatic event over a month ago and suffer from frequent nightmares. Participants must be stable on bipolar medication for at least two months and not currently experiencing mania/hypomania, recent suicide attempts, hospitalizations, or untreated substance use disorders.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Exposure, Relaxation, and Rescripting Therapy (ERRT) for Bipolar disorder once a week for five consecutive weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment with assessments at 1-week, 3-months, and potentially 1-year
Participant Groups
ERRT-Bipolar Disorder is already approved in United States for the following indications:
- Trauma-related nightmares
- Sleep disturbances in trauma-exposed adults with bipolar disorder